Tom Brady partners with eMed to broaden GLP-1 weight loss drug access
NFL legend Tom Brady has partnered with digital health company eMed to increase access to GLP-1 weight loss medications. The collaboration aims to expand telehealth services and prescription options for patients seeking these drugs. This move highlights the growing intersection of celebrity influence and the booming weight-loss pharmaceutical market.